Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

EXtubationsrelaterade komplikationer - EXTUBE-studien (EXTUBE) (EXTUBE)

19 oktober 2026 uppdaterad av: University Health Network, Toronto

EXtubationsrelaterade komplikationer - en internationell observationsstudie för att förstå effekten och bästa praxis i operationssalen och intensivvårdsavdelningen - EXTUBE-studien

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Studieöversikt

Status

Rekrytering

Betingelser

Detaljerad beskrivning

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Studietyp

Observationell

Inskrivning (Beräknad)

3000

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

    • New South Wales
      • Sydney, New South Wales, Australien, 2065
        • Avslutad
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Australien, 3135
        • Avslutad
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Australien, 3156
        • Avslutad
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Australien, 3076
        • Avslutad
        • The Northern Hospital
      • Melbourne, Victoria, Australien, 3128
        • Avslutad
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Australien, 3084
        • Avslutad
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Australien, 3079
        • Avslutad
        • Austin Health - Heidelberg Repatriation Hospital
      • Piedecuesta, Colombia
        • Avslutad
        • Hospital Internacional de Colombia
    • Arizona
      • Tucson, Arizona, Förenta staterna, 85724-5114
        • Avslutad
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Förenta staterna, 72205
        • Avslutad
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Förenta staterna, 32608
        • Avslutad
        • University of Florida
    • Illinois
      • Chicago, Illinois, Förenta staterna, 60637
        • Avslutad
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Förenta staterna, 97239
        • Avslutad
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Förenta staterna, 77030
        • Avslutad
        • The University of Texas Health Science Center
      • Castlebar, Irland, F23 H529
        • Avslutad
        • Mayo University Hospital
      • Cork, Irland, T12 DFK4
        • Avslutad
        • Cork University Hospital
      • Dublin, Irland, D07 R2WY
        • Avslutad
        • Mater Misericordiae University Hospital
      • Galway, Irland, H91 YR71
        • Avslutad
        • Galway University Hospitals
      • Waterford, Irland, X91 ER8E
        • Har inte rekryterat ännu
        • University Hospital Waterford
        • Kontakt:
        • Kontakt:
        • Huvudutredare:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Underutredare:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
    • British Columbia
      • Surrey, British Columbia, Kanada, V3V 1Z2
        • Avslutad
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Kanada, E1C 4B7
        • Avslutad
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Kanada, M4N 3M5
        • Avslutad
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Kanada, L2S 0A9
        • Avslutad
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Kanada, M5B 1W8
        • Avslutad
        • St. Michael's Hospital
      • Toronto, Ontario, Kanada, M5G 1X5
        • Avslutad
        • Mount Sinai Hospital
      • Toronto, Ontario, Kanada, M5G 2C4
        • Rekrytering
        • University Health Network - Toronto General Hospital
        • Kontakt:
        • Huvudutredare:
          • Matteo Parotto, MD, PhD
        • Kontakt:
        • Underutredare:
          • Alicia Grassi, MD
      • Toronto, Ontario, Kanada, M5T 2S8
        • Avslutad
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Kanada, H2X 0C1
        • Avslutad
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Kuwait City, Kuwait
        • Avslutad
        • Amiri Hospital
      • Auckland, Nya Zeeland, 1023
        • Avslutad
        • Auckland City Hospital
      • Invercargill, Nya Zeeland, 9812
        • Avslutad
        • Southland Hospital
      • Rotorua, Nya Zeeland, 3010
        • Avslutad
        • Rotorua Hospital
      • Singapore, Singapore, 308433
        • Avslutad
        • Tan Tock Seng Hospital
      • Bath, Storbritannien, BA1 3NG
        • Avslutad
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Storbritannien, NE7 7DN
        • Avslutad
        • Freeman Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Beskrivning

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiv: PROSPECTIVE

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Tidsram: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Difficult airway and complications related to airway management if reintubation is required
Tidsram: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Tidsram: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Tidsram: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Tidsram: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Tidsram: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Tidsram: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Tidsram: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Tidsram: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Tidsram: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Tidsram: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Tidsram: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Tidsram: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Matteo Parotto, MD, PhD, UHN

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

14 april 2025

Primärt slutförande (Beräknad)

1 december 2027

Avslutad studie (Beräknad)

1 december 2027

Studieregistreringsdatum

Först inskickad

28 mars 2024

Först inskickad som uppfyllde QC-kriterierna

3 juni 2024

Första postat (Faktisk)

5 juni 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

22 oktober 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

19 oktober 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 24-5811
  • 4850 (Annan identifierare: Clinical Trials Ontario - CTO)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera